Our Bristol Myers Squibb Stock Pick Is Up 35%. It's Still a Good Bet in Healthcare.

Our Bristol Myers Squibb Stock Pick Is Up 35%. It's Still a Good Bet in Healthcare.

来源:Barrons发布于 2026-11-12

The stock is still attractive trading at 10 times forward earnings.

相关标的:BMY

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。